Psoriasis vaccine (Immune Response BioPharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePsoriasis vaccine (Immune Response BioPharma)
Drug Alias Name牛皮癣疫苗 - Immune Response BioPharmaZorcellIR-502
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmune Response Corp
China Registration ClassN/A

Develop Information

Active CompaniesImmune Response Corp
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A